PDSB · PDS Biotechnology Corp · Investor Relations
$0.29
-0.01 (-2.33%)
At close · Sep 9
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these uncertainties, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of these unaudited Condensed Consolidated Financial Statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$16.40M
Shares
55.97M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-13 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-30 | Earnings conference call (announced in 8-K) | Earnings call |
| 2025-03-28 | 28 MARCH 2025 PDS BIOTECH LEADERSHIP TO PRESENT AT 2025 CAGLA NEAUXCANCER CONFERENCE | Conference |
Key facts
CIK
1472091
CUSIP
70465T107
13F (30d)
38 filings
38 filers
Visit website
Investor relations